Dolasetron Mesylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 4 USDMF, 1 EU WC, 3 NDC API, 2 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

7 FDF Dossiers, 5 FDA Orange Book, 1 South Africa, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 50MG, INJECTABLE;INJECTION - 100MG/5ML (20MG/ML), INJECTABLE;INJECTION - 12.5MG/0.625ML (20MG/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 15 SPI Pharma, 2 Seqens, 3 DKSH, 2 Jai Radhe Sales, 7 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 13 BASF, 10 Corel Pharma Chem, 1 DFE Pharma, 2 Finar, 8 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 2 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 40 Fillers, Diluents & Binders, 23 Direct Compression, 21 Controlled & Modified Release, 17 Solubilizers, 17 Disintegrants & Superdisintegrants, 14 Taste Masking, 14 Chewable & Orodispersible Aids, 13 Topical, 12 Thickeners and Stabilizers, 12 Parenteral, 11 Film Formers & Plasticizers, 11 Co-Processed Excipients, 11 Granulation, 8 Lubricants & Glidants, 6 Emulsifying Agents, 5 Coloring Agents, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 3 Rheology Modifiers, 2 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 2 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20623 / DOSAGE - TABLET;ORAL - 100MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
dolasetron mesylate(UNII: U3C8E5BWKR) (dolasetron - UNII:82WI2L7Q6E)	dolasetron mesylate	100mg \| 50mg

Inactive Ingredients

Ingredient Name	Avera McKennan Hospital	sanofi-aventis U.S. LLC	Validus Pharmaceuticals LLC
carnauba wax(R12CBM0EIZ)
croscarmellose sodium(M28OL1HH48)
ferric oxide red(1K09F3G675)
ferrosoferric oxide(XM0M87F357)
HYPROMELLOSES(3NXW29V3WO)
LACTOSE(J2B2A4N98G)
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
MAGNESIUM STEARATE(70097M6I30)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
polyethylene glycols(3WJQ0SDW1A)
polysorbate 80(6OZP39ZG8H)
propylene glycol(6DC9Q167V3)
SHELLAC(46N107B71O)
STARCH, CORN(O8232NY3SJ)
STARCH, PREGELATINIZED CORN(O8232NY3SJ)
TITANIUM DIOXIDE(15FIX9V2JP)
WHITE WAX(7G1J5DA97F)

Drug Product Composition: Dolasetron Mesylate